Olopatadine Ophthalmic Solution 7 mg
Therapeutic Class: Anti Allergic
Therapeutic Class: Anti Allergic
Indications:
This drug is indicated for the treatment of the sign and symptoms of allergic conjunctivitis (itchy, watery, red, irritated eyes).
Presentation:
Olopatadine Max Sterile Eye Drops: Each ml eye drop contains Olopatadine
Hydrochloride USP is equivalent to Olopatadine 7 mg.
Description:
Olopatadine is an inhibitor of the release of histamine from the mast cell and a relatively selective histamine H 1 -antagonist that inhibits histamine-induced inflammatory effects on human conjunctival epithelial cells.
Dosage & Administration:
Adults and children (age 2 years and above)
One drop in the conjunctival sac of the affected eye(s) once daily.
Side Effects:
Following adverse effects can be seen in some patients:
Headache, asthenia, blurred vision, burning or stinging, cold syndrome, dry
eye, foreign body sensation, hyperaemia, hypersensitivity, keratitis, lid edema,
nausea, pharyngitis, pruritus, rhinitis, sinusitis.
Precautions:
To prevent contaminating the dropper tip and solution, care should be taken not
to touch the eyelids or surrounding areas with the dropper tip of the bottle.
Patients should be advised not to wear a contact lens if their eye is red.
Use in Pregnancy & Lactation:
Pregnancy: Pregnancy category C. For this drug, no clinical data on exposed
pregnancies are available.
Lactation: It is not known if this medicine passes into breast milk, therefore it is
not recommended for use during breastfeeding.
Interaction:
Interactions with other medications have not been investigated in vivo.
Overdose:
No information is available.
Storage:
Keep out of the reach of children. Store in a cool, dry place, away from heat and direct light.
Do not use more than 4 weeks after opening
This drug is indicated for the treatment of the sign and symptoms of allergic conjunctivitis (itchy, watery, red, irritated eyes).
Presentation:
Olopatadine Max Sterile Eye Drops: Each ml eye drop contains Olopatadine
Hydrochloride USP is equivalent to Olopatadine 7 mg.
Description:
Olopatadine is an inhibitor of the release of histamine from the mast cell and a relatively selective histamine H 1 -antagonist that inhibits histamine-induced inflammatory effects on human conjunctival epithelial cells.
Dosage & Administration:
Adults and children (age 2 years and above)
One drop in the conjunctival sac of the affected eye(s) once daily.
Side Effects:
Following adverse effects can be seen in some patients:
Headache, asthenia, blurred vision, burning or stinging, cold syndrome, dry
eye, foreign body sensation, hyperaemia, hypersensitivity, keratitis, lid edema,
nausea, pharyngitis, pruritus, rhinitis, sinusitis.
Precautions:
To prevent contaminating the dropper tip and solution, care should be taken not
to touch the eyelids or surrounding areas with the dropper tip of the bottle.
Patients should be advised not to wear a contact lens if their eye is red.
Use in Pregnancy & Lactation:
Pregnancy: Pregnancy category C. For this drug, no clinical data on exposed
pregnancies are available.
Lactation: It is not known if this medicine passes into breast milk, therefore it is
not recommended for use during breastfeeding.
Interaction:
Interactions with other medications have not been investigated in vivo.
Overdose:
No information is available.
Storage:
Keep out of the reach of children. Store in a cool, dry place, away from heat and direct light.
Do not use more than 4 weeks after opening